Unravelling the cardiovascular effects induced by α-terpineol: A role for the nitric oxide-cGMP pathway

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 8, 2010, Pages 811-816

  Ribeiro, Thaís P ^a   Porto, Dayanne L ^a   Menezes, Camilla P ^a   Antunes, Alessandra A ^b   Silva, Darízy F ^a   De Sousa, Damião P ^c   Nakao, Lia S ^b   Braga, Valdir A ^a   Medeiros, Isac A ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

hypotension; monoterpene; nitric oxide; rabbit aorta endothelial cells; vasodilatation

Indexed keywords

1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; CYCLIC GMP; HYDROXOCOBALAMIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; TERPINEOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CELL LINE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVATION; HEART RATE; HYPOTENSION; IN VIVO STUDY; MALE; MESENTERIC ARTERY; MUSCLE RELAXATION; NONHUMAN; RAT; TACHYCARDIA; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; CELL LINE; CYCLIC GMP; CYCLOHEXENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HEART RATE; MALE; MESENTERIC ARTERIES; MONOTERPENES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 77955116044     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05383.x     Document Type: Article

References (47)

1. Almeida RN, Motta SC, Leite JR. Óleos essenciais com propriedades anticonvulsivantes. Bol. Latin. Am. Carib. Plant. Med. Aromat. 2003 2:3 6.
2. De Sousa DP, Gonçalves JC, Quintans-Junior L, Cruz JS, Araújo DA, De Almeida RN. Study of anticonvulsant effect of citronellol, a monoterpene alcohol in rodents. Neurosci. Lett. 2006 401:231 235.
3. Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H. Anti-inflammatory activity of 1,8-cineol (eucalyptol) in bronchial asthma: A double-blind placebo-controlled trial. Respir. Med. 2003 97:250 256. (Pubitemid 36266881)
4. Guedes DN, Silva DF, Barbosa-Filho JM, Medeiros IA. Muscarinic agonist properties involved in the hypotensive and vasorelaxing responses of rotundifolone in rats. Planta Med. 2002 68:700 704.
5. Santos MR, Carvalho AA, Medeiros IA, Alves PB, Marchioro M, Antoniolli AR. Cardiovascular effects of Hyptis fruticosa essential oil in rats. Fitoterapia 2007 78:186 191.
6. Bastos JF, Moreira IJ, Ribeiro TP et al. Hypotensive and vasorelaxant effects of citronellol, a monoterpene alcohol, in rats. Basic Clin. Pharmacol. Toxicol. 2010 106:331 337.
7. Grassmann J. Terpenoids as plant antioxidants. Vitam. Horm. 2005 72:505 535.
8. Lahlou S, Leal-Cardoso JH, Magalhães PJ. Essential oil of Croton nepetaefolius decreases blood pressure through an action upon vascular smooth muscle: Studies in DOCA-salt hypertensive rats. Planta Med. 2000 66:138 143.
9. Edris AE. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother. Res. 2007 21:308 323.
10. Wagner KH, Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Ann. Nutr. Metab. 2005 47:95 106.
11. Gonçalves JCR, Oliveira FS, Benedito RB, De Sousa DP, Almeida RN, Araújo DAM. Antinociceptive activity of (-)-carvone: Evidence of association with decreased peripheral nerve excitability. Biol. Pharm. Bull. 2008 31:1017 1020.
12. Ferreira-da-Silva FW, Barbosa R, Júnior L et al. Effects of 1,8-cineole on electrophysiological parameters of neurons of the rat superior cervical ganglion. Clin. Exp. Pharmacol. Physiol. 2009 36:1068 1073.
13. Sterner O, Szallasi A. Novel natural vanilloid receptor agonists: New therapeutic targets for drug development. Trends Pharmacol. Sci. 1999 20:459 465.
14. Vogt-Eisele AK, Weber K, Sherkheli MA et al. Monoterpenoid agonists of TRPV3. Br. J. Pharmacol. 2007 151:530 540.
15. Parnas M, Peters M, Dadon D et al. Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium 2009 45:300 309.
16. Bakkali F, Averbeck S, Averbec D, Idaomar M. Biological effects of essential oils: A review. Food Chem. Toxicol. 2008 46:446 475.
17. Barbosa-Filho JM, Cunha RM, Dias CS et al. GC-MS analysis and cardiovascular activity of the essential oil of Ocotea duckei. Rev. Bras. Farmacogn. 2008 18:56 61 (Article in English).
18. Kelen M, Tepe B. Chemical composition, antioxidant and antimicrobial properties of the essential oils of three Salvia species from Turkish flora. Bioresour. Technol. 2008 99:4096 4104.
19. Feitosa EMA, Arriaga AMC, Santiago GMP et al. Chemical composition and larvicidal activity of Rollinia leptopetala (Annonaceae). J. Braz. Chem. Soc. 2009 20:375 378.
20. Tobin T, Swerczek TW, Blake JW. Pine oil toxicity in the horse: Drug detection, residues and pathological changes. Res. Commun. Chem. Pathol. Pharmacol. 1976 15:291 301.
21. Ponce-Monter H, Campos MG, Pérez S et al. Chemical composition and antispasmodic effect of Casimiroa pringlei essential oil on rat uterus. Fitoterapia 2008 76:446 450.
22. Saito K, Okabe T, Inamori Y et al. The biological properties of monoterpenes hypotensive effects on rats and antifungal activites on plant pathogenic fungi of monoterpenes. Mokuzai Gakkaishi 1996 42:677 680 (Article in Japanese with English summary).
23. Magalhães PJC, Criddle DN, Tavares RA, Melo EM, Mota TL, Leal-Cardoso JH. Intestinal myorelaxant and anti-spasmodic effects of the essential oil of Croton nepetaefolius, and its constituents cineole, methyl-eugenol and terpineol. Phytother. Res. 1998 12:172 177.
24. Porto DL, Silva DF, Dias KLG et al. Evaluation of the vasorelaxant activity induced by α-terpineol and analogous. In:Sociedade Brasileira de Farmacologia e Terapêutica Experimental (eds). 38th Congresso Brasileiro de Farmacologia e Terapêutica Experimental, 2006, Ribeirão Preto, São Paulo, Brasil. Abstract in English n.08.023.
25. Oliveira EJ, Medeiros IA, Mukherjee R. Hypotensive and spasmolytic effects of normacusine B from Strychnos atlantica roots. Phytomedicine 1996 3:45 9.
26. Altura BM, Altura BT. Differential effects of substrate on drug-induced contractions of rabbit aorta. Am. J. Physiol. 1970 219:1698 1705.
27. Furchgott FF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288:373 376.
28. Moncada S, Higgs EA. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 1993 29:2002 2012.
29. Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of bood vessels. Pharmacol. Rev. 2003 55:271 324.
30. Kruszyna H, Magyar JS, Rochelle LG, Russel MA, Smith RPE, Wilcox DE. Spectroscopic studies of nitric oxide (NO) interations with cobalamins: Reaction of NO with hydroxocobalamin (Iii) likely accounts for cobalamin reversal of the biological effects of NO. J. Pharmacol. Exp. Ther. 1998 285:665 671.
31. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 1995 48:184 188.
32. Caulfield MP, Birdsall NJ. International Union of Pharmacology XVII classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 1998 50:279 290.
33. Vanhoutte PM. COX-1 and vascular disease. Clin. Pharmacol. Ther. 2009 86:212 215.
34. Kojima H, Nakatsubo N, Kikuchi K et al. Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Anal. Chem. 1998 70:2446 2453.
35. Navarro-Antolin J, Lamas S. Nitrosative stress by cyclosporine A in the endothelium: Studies with the NO-sensitive probe diaminofluorescein-2/diacetate using flow cytometry. Nephrol. Dial. Transplant. 2001 16 (Suppl. 1 6 9.
36. Moncada S, Palmer R, Higgs EA. Nitric oxide. Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991 43:109 142.
37. Chowdhary S, Townend JN. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin. Sci. 1999 97:5 17.
38. Charkoudian N, Rabbitts JA. Sympathetic neural mechanisms in human cardiovascular health and disease. Mayo Clin. Proc. 2009 84:822 830.
39. Kishi T, Hirooka Y, Kimura Y et al. Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRSP. Hypertension 2003 41:255 260.
40. A receptor: Effects of thymol. Eur. J. Pharmacol. 2008 600:26 31.
41. Magalhães PJC, Lahlou S, Juca DM et al. Vasorelaxation induced by the essential oil of Croton nepetaefolius and its constituents in rat aorta are partially mediated by the endothelium. Fundam. Clin. Pharmacol. 2008 22:169 177.
42. Rajapakse N, Mattson DL. Role of l-arginine in nitric oxide production in health and hypertension. Clin. Exp. Pharmacol. Physiol. 2009 36:249 255.
43. + channel, Also, is a target of cGMP-dependent protein kinase phosphorylation in vivo. J. Biol. Chem. 1998 273:32950 32956.
44. Wanstall JC, Homer KL, Doggrell SA. Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr. Vasc. Pharmacol. 2005 3:41 53.
45. Chiou WF, Chang PC, Chou CJ, Chen CF. Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis. Life Sci. 2000 66:1369 1376.
46. Kang DG, Lee KJ, Choi DH, Sohn EJ, Moon MK, Lee HS. Vascular relaxation by the methanol extract of Sorbus cortex via NO-cGMP pathway. Biol. Pharm. Bull. 2005 28:860 864.
47. Nakatsuboa N, Kojimaa H, Kazuya K, Nagoshib H, Hiratab Y, Maedaa D, Imaia Y, Irimuraa T, Naganoa T. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofuoresceins. FEBS Letters 1998 427:263 266.